Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817160-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 31, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
28,527
Total Value
$81,249.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 3,207 | $0.00 | $0.00 | 79,958 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 81,958 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 85,708 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,859 | $0.00 | $0.00 | 88,567 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 30, 2026 | Sale | 4,797 | $16.58 | $79,546.73 | 83,770 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 30, 2026 | Sale | 98 | $17.37 | $1,702.43 | 83,672 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 3,207 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 2,000 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 18,750 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,859 | $0.00 | $0.00 | 25,725 | Direct | โ | View Details |